Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]

Zaire Ebolavirus Glycoprotein-directed Antibody [EPC] was reported 3 times

These side effects are most commonly reported by patients taking drugs of the Zaire Ebolavirus Glycoprotein-directed Antibody [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
1 EBOLA DISEASE 1
2 FOETAL EXPOSURE DURING PREGNANCY 1
3 LOW BIRTH WEIGHT BABY 1
4 MATERNAL EXPOSURE DURING PREGNANCY 1
5 OFF LABEL USE 1
6 POSTPARTUM HAEMORRHAGE 1
7 PREMATURE BABY 1
8 PREMATURE DELIVERY 1